Macrogenics reported $-40279000 in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US $ 2333M 204M
AstraZeneca AZN:LN 1.4B 366M
Biogen BIIB:US $ 858.6M 171.5M
Bristol Myers Squibb BMY:US $ 2967M 411M
Cerulean Pharma CERU:US $ -9162930 1.47M
Daiichi Sankyo 4568:JP 45.77B 71.44B
Dicerna Pharmaceuticals DRNA:US $ -40244000 11.14M
Eli Lilly And LLY:US $ 1428.4M 237.8M
Epizyme EPZM:US $ -58231000 6.11M
Genmab GEN:DC 787M 255M
Gilead Sciences GILD:US $ 2262M 639M
Immunogen IMGN:US $ -27369000 1.55M
Johnson & Johnson JNJ:US $ 7033M 2723M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Macrogenics MGNX:US $ -40279000 11.01M
Merk MRK:US $ 3930M 332M
Mirati Therapeutics MRTX:US $ -164186000 31.76M
Pfizer PFE:US $ 6662M 905M
Puma Biotechnology PBYI:US $ -16633000 36.78M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Seattle Genetics SGEN:US $ -89603000 32.82M
Xencor XNCR:US $ 9.09M 24.76M